Case Study On Small Bone Innovations to be Presented
NEW YORK, March 26, 2007 (PRIME NEWSWIRE) -- Small Bone Innovations, Inc. (SBi), a single-source provider of innovation, products, technology and education for the small bone & joint sector of the orthopedic industry, is pleased to announce that its Founder, Chairman & CEO, Anthony G. Viscogliosi will highlight a roundtable discussion and dinner on current and future key issues in the global orthopedics market.
Entitled "Orthopedics - The New Era: Technology, Business and Regulatory Trends," the roundtable dinner meeting will be held on Tuesday, March 27th at 3:30pm at the Dan Hotel in Tel-Aviv, Israel. This ground-breaking event is being co-hosted by Ernst & Young, one of the world's leading professional service organizations, along with Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) and Viscogliosi Bros., LLC (VB), the New York-based merchant banking, venture capital, and investment banking firm devoted to the orthopedics sector of the healthcare market.
Mr. Viscogliosi will be providing those in attendance with a presentation entitled: "Past, Current & Future Trends in the Orthopedics Market - Outlook for Opportunities in the Global Musculoskeletal Industry for the next 15 Years."
Additionally, he will be presenting two specific case studies: "Spine Solutions, Inc. - A Case Study Presentation - A Single Technology Model for Success" and "Small Bone Innovations, Inc. - A Case Study Presentation - A Multi-Product Business Model for Success."
In addition to Mr. Viscogliosi, experts from the clinical, regulatory and intellectual property powerhouse, MCRA, including the former Chief of the Orthopedics Branch at the United States Food & Drug Administration (FDA), will be participating. There will be opportunities for question-and-answer exchanges as well.
Commenting on his appearance in Israel, Mr. Viscogliosi said, "Since our inception just over two short years ago, SBi has continued to spread globally, and to date, has had sales of its innovative implant systems and devices in nearly fifty countries. I look forward to participating in what will surely be a fruitful and informative roundtable, and am proud to share the SBi story of success with Israel's leading orthopedic and bio-materials companies, researchers, surgeons and technology professionals."
About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Bros., LLC, (VB), the New York-based merchant banking firm that specializes in the musculoskeletal /orthopedic sector. VB created SBi as the first company to focus purely on small bone & joint science. By integrating established companies and professionals in the field, SBi today offers a broad, clinically proven portfolio of innovation, products, technologies and education to treat trauma and disease in small bones & joints.
In establishing SBi, VB acquired several prominent U.S., Canadian and European orthopedic device companies and product technology licenses focused on small bone and joint treatment, including arthroplasty, internal & external fixation, trauma, and tissue technology.
SBi was a 2006 recipient of Red Herring magazine's annual "Red Herring 100 North America" award, recognized as one of the nation's leading technology companies and the only orthopedic device company selected among an initial entry of more than one thousand firms.
Additionally, SBi's Artelon CMC-I Spacer, developed for patients with thumb base osteoarthritis, was featured on the cover and highlighted within Medical Design Technology magazine's "Year of Innovation" issue as one of the most fascinating technologies influencing the medical device industry.
Medical Device & Diagnostic Industry Magazine named SBi to their list of "50 Companies to Watch" in 2006, noting, "Small Bone Innovations is going against the grain in its determination to become a market leader in the small bone & joint device sector."
For more information on SBi, please visit: www.totalsmallbone.com
The Small Bone Innovations, Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=3091
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry.
Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total of more than 40 years' experience analyzing and investing in the musculoskeletal/orthopedics sector, directing literally billions of dollars through the orthopedics industry. They have pioneered innovative financial, strategic and management initiatives for nearly 150 companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.
For more information about VB, please visit: www.vbllc.com
Forward-looking statements
This press release may contain forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.